- Home
- TATT vs AQST Comparison
TATT vs AQST Comparison
Compare TATT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TATT
- AQST
- Stock Information
- Founded
- TATT 1985
- AQST 2004
- Country
- TATT Israel
- AQST United States
- Employees
- TATT N/A
- AQST N/A
- Industry
- TATT Aerospace
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- TATT Industrials
- AQST Health Care
- Exchange
- TATT Nasdaq
- AQST Nasdaq
- Market Cap
- TATT 384.2M
- AQST 390.4M
- IPO Year
- TATT 1987
- AQST 2018
- Fundamental
- Price
- TATT $35.45
- AQST $3.96
- Analyst Decision
- TATT Strong Buy
- AQST Strong Buy
- Analyst Count
- TATT 3
- AQST 7
- Target Price
- TATT $36.00
- AQST $11.29
- AVG Volume (30 Days)
- TATT 99.5K
- AQST 1.1M
- Earning Date
- TATT 08-27-2025
- AQST 08-11-2025
- Dividend Yield
- TATT N/A
- AQST N/A
- EPS Growth
- TATT 81.73
- AQST N/A
- EPS
- TATT 1.14
- AQST N/A
- Revenue
- TATT $160,170,000.00
- AQST $54,228,000.00
- Revenue This Year
- TATT $22.42
- AQST N/A
- Revenue Next Year
- TATT $18.78
- AQST $51.62
- P/E Ratio
- TATT $30.04
- AQST N/A
- Revenue Growth
- TATT 30.57
- AQST 5.29
- 52 Week Low
- TATT $12.61
- AQST $2.12
- 52 Week High
- TATT $36.99
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- TATT 63.26
- AQST 50.64
- Support Level
- TATT $31.01
- AQST $3.73
- Resistance Level
- TATT $36.99
- AQST $4.10
- Average True Range (ATR)
- TATT 1.45
- AQST 0.22
- MACD
- TATT 0.33
- AQST -0.07
- Stochastic Oscillator
- TATT 66.06
- AQST 17.42
About TATT TAT Technologies Ltd.
TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.